Table 3.
Associations of Friedewald and direct LDL cholesterol with cardiovascular disease events
Per 1-quintile increase | P for linear trend | |||||
---|---|---|---|---|---|---|
Quintile 1 | Quintile 2 | Quintile 3 | Quintile 4 | Quintile 5 | ||
Range | ||||||
Friedewald, fasting | <102.3 mg/dL | 102.3–120.6 | 120.7–137.9 | 138.0–159.6 | >159.6 | |
Direct, fasting | <97.8 mg/dL | 97.8–115.5 | 115.6–132.2 | 132.3–153.9 | >153.9 | |
Direct, nonfasting | <97.8 mg/dL | 97.8–115.5 | 115.6–132.2 | 132.3–153.9 | >153.9 | |
HR (95% CI) | ||||||
Friedewald, fasting | 1.00 | 1.21 (0.90–1.62) | 1.40 (1.06–1.85) | 1.65 (1.26–2.16) | 1.93 (1.49–2.51) | <0.001 |
Direct, fasting | 1.00 | 1.31 (0.97–1.77) | 1.53 (1.15–2.05) | 1.99 (1.51–2.63) | 2.11 (1.60–2.78) | <0.001 |
Direct, nonfasting | 1.00 | 0.96 (0.59–1.55) | 1.25 (0.79–1.98) | 1.16 (0.73–1.85) | 1.20 (0.74–1.93) | 0.33 |
Per 1-SD increase | Per 10 mg/dL increase | P | ||||
HR (95% CI) | ||||||
Friedewald, fasting | 1.22 (1.14–1.30) | 1.06 (1.04–1.08) | <0.001 | |||
Direct, fasting | 1.23 (1.15–1.32) | 1.06 (1.04–1.08) | <0.001 | |||
Direct, nonfasting | 1.03 (0.89–1.18) | 1.01 (0.97–1.05) | 0.72 |
HRs and 95% CIs were adjusted for age, randomized treatment assignment, smoking status, menopausal status, postmenopausal hormone use, blood pressure, diabetes, and body mass index. P value for linear trend was obtained using the median value for each quintile. Fasting was defined as ≥ 8 hours from last meal.